Early in HIV infection, increased IFNα levels are considered to restrict infection, i.e., they are beneficial, whereas elevated levels later in disease are associated with disease progression, with increased viral loads and decreased CD4+ T cell counts (91, 92). This evidence concerns the gene IFNA2 and HIV infectious disease.